Carregant...
Should all patients with Hodgkin lymphoma who relapse after autologous SCT be considered for allogeneic SCT?
This article has a companion Counterpoint by Moskowitz.
Guardat en:
| Publicat a: | Blood Adv |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society of Hematology
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5894255/ https://ncbi.nlm.nih.gov/pubmed/29636327 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2017011122 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|